Abstract:The mechanism underlying bladder cancer metastasis is associated with tumor angiogenesis. The present study aimed to evaluate the predictive role and value of an angiogenesis‐associated long non‐coding (lnc)RNA signature in patients with bladder cancer and the role of long intergenic non‐coding RNA (LINC)02321 in the progression of this malignancy. Angiogenesis‐related lncRNAs were screened using Pearson correlation analysis and the signaturewas constructed using Cox regression analysis and evaluated using the receiver operating characteristic curve. LINC02321, which expressed the largest difference in bladder cancer, was screened using reverse transcription‐quantitative PCR. The role of LINC02321 in the malignant progression of bladder cancer was evaluated using Transwell, wound healing and Cell Counting Kit 8 assays. A total of six angiogenesis‐associated lncRNAs (USP30‐AS1, LINC02321, PSMB8‐AS1, KRT7‐AS, LINC01767 and OCIAD1‐AS1) were identified as candidates for the prognostic signature using Cox regression analysis. The overall survival of patients in the low‐risk group was significantly longer compared with that in the high‐risk group, with the highest area under the curve value being 0.807. A nomogram was constructed based on the traditional clinical indicators (age, sex, grade, American Joint Committee on Cancer stage) and risk score of patients. Compared with the traditional clinical indicators, the risk score demonstrated better clinical prediction capacity for predicting the prognosis of patients with bladder cancer. The Cancer Genome Atlas prediction and RT‐qPCR experimental results demonstrated that only LINC02321 was highly expressed in bladder cancer tissue and promoted the proliferation, invasion, migration and cisplatin resistance of the malignancy. Gene set enrichment, Pearson's correlation analysis and experimental results demonstrated that the VEGFA signalling pathway may be involved in the LINC02321‐regulated progression of bladder cancer. In conclusion, the six angiogenesis‐associated lncRNA signatures reported in the present study may be used to predict the prognosis of patients with bladder cancer, and LINC02321 promoted malignant progression of bladder cancer via the VEGFA signalling pathway.

Long non-coding RNA LINC02446 suppresses the proliferation and metastasis of bladder cancer cells by binding with EIF3G and regulating the mTOR signalling pathway

Long Noncoding RNA SNHG14 Promotes Breast Cancer Cell Proliferation and Invasion Via Sponging Mir-193A-3p

Biological functions and clinical significance of long noncoding RNAs in bladder cancer

High LINC00536 Expression Promotes Tumor Progression and Poor Prognosis in Bladder Cancer

LINC01106 Post-Transcriptionally Regulates ELK3 and HOXD8 to Promote Bladder Cancer Progression

LINC00461 promotes bladder cancer cells EMT through miR-518b/HNRNPUL1 axis

Abstract 991: Long Non-Coding RNA LINC01133 Inhibits Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer by Interacting with SRSF6

LINC00978 Promotes Bladder Cancer Cell Proliferation, Migration and Invasion by Sponging Mir‑4288.

A novel long non‐coding RNA LINC00524 facilitates invasion and metastasis through interaction with TDP43 in breast cancer

LncRNA MBNL1-AS1 represses cell proliferation and enhances cell apoptosis via targeting miR-135a-5p/PHLPP2/FOXO1 axis in bladder cancer

A novel LINC02321 promotes cell proliferation and decreases cisplatin sensitivity in bladder cancer by regulating RUVBL2

LINC00882, Transcriptionally Activated by CEBP-β and Post-Transcriptionally Stabilized by METTL14-mediated M6a Modification, Exerts Tumorigenesis by Promoting PABPC1-mediated Stabilization of ELK3 Mrna

Exosomes‐mediated transfer of long noncoding RNA LINC01133 represses bladder cancer progression via regulating the Wnt signaling pathway

LINC00882 , transcriptionally activated by CEBP-β and post-transcriptionally stabilized by METTL14-mediated m 6 A modification, exerts tumorigenesis by promoting PABPC1-mediated stabilization of ELK3 mRNA

LINC01451 drives epithelial-mesenchymal transition and progression in bladder cancer cells via LIN28/TGF-β/Smad pathway

Long Noncoding RNA AC114812.8 Promotes the Progression of Bladder Cancer Through Mir-371B-5p/fut4 Axis.

Lncrna H19 Regulates Epithelial-Mesenchymal Transition and Metastasis of Bladder Cancer by Mir-29B-3p As Competing Endogenous RNA

An angiogenesis‐related lncRNA signature for the prognostic prediction of patients with bladder cancer and LINC02321 promotes bladder cancer progression via the VEGFA signaling pathway

Long Non‑coding RNA 00858 Knockdown Alleviates Bladder Cancer Via Regulation of the Mir‑3064‑5p/ctgf Axis.

LINC01410 leads the migration, invasion and EMT of bladder cancer cells by modulating miR-4319 / Snail1

LncRNA NRON Promotes the Proliferation, Metastasis and EMT Process in Bladder Cancer